Stock listing

Galderma Group Ag

Selected listing: A407X6 · LS · EUR · DE

Galderma Group Ag (Lang & Schwarz: A407X6), Health Technology. Latest release Sep 16, 2026: Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness…

A407X6:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A407X6
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Galderma Group Ag

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

September 16, 2026

Galderma opens new U.S. and Latin America headquarters in Miami

August 24, 2026

Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

August 11, 2026

Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year

July 23, 2026

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

July 20, 2026

All Galderma Group Ag news →

Events

Replays

Galderma Group Ag (GDERF) Q2 2026 Earnings Call
Thu, Jul 23, 2026 · 07:00 AM ET
Watch
Galderma Group Ag (GDERF) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 08:00 AM ET
Watch
Galderma Group Ag (GDERF) Q3 2025 Earnings Call
Thu, Oct 23, 2025 · 03:30 PM ET
Watch

Research Galderma Group Ag

Galderma Group Ag company profile

View the public company page for Galderma Group Ag on 6ix.

Galderma Group Ag news

Read company news and market updates connected to Galderma Group Ag.

Galderma Group Ag investor events

Find investor webinars, events, and replay context for Galderma Group Ag.